A phase 2 study showed that giving maintenance regorafenib could delay disease progression in patients with non-adipocytic ...

Telix Pharmaceuticals Limited’s TLX share price has dipped by 7.55%, which has investors questioning if this is right time to ...

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) shares are trading higher on Monday after the company inked a deal to be ...

Edgewood Oncology, a clinical-stage biotechnology company focused on delivering BTX-A51 to patients with hematologic ...

Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland ...